))
Meet Biljana Naumovic, President of U.S. Oncology, Solid Tumor at Johnson & Johnson...
Manage episode 454955078 series 3623299
A tartalmat a Dave Bjork biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a Dave Bjork vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.
On today’s episode, meet Biljana Naumovic. Biljana is the President of U.S. Oncology, Solid Tumor at Johnson & Johnson, where she is spearheading innovative cancer treatments and advocating for equity in healthcare.
She is committed to advancing the organization’s solid tumor portfolio and pipeline, spanning prostate, bladder, and lung cancer, as well as multiple novel treatment pathways. Biljana is passionately focused on bringing medical innovation and ultimately transforming patient care.
Biljana is a physician by training and graduated in 2001 from the Belgrade University Medical School. She worked as a practicing physician for several years before transitioning to industry. She also holds an executive education degree from the London Business School.
researchevangelist.com
Egy epizód
Megosztás
